The NHS is restricting the use of cholinesterase inhibitors to those with moderate Alzheimer’s disease or worse. The efficacy data for mild dementia is minimal – with up to 30 to 50 percent showing no improvement.
The NHS is restricting the use of cholinesterase inhibitors to those with moderate Alzheimer’s disease or worse
Real physician voices, twice a week
Free, and one click to unsubscribe.
Keep reading
The Podcast
Latest episodes
Most popular
Hidden fees in employer health plans are about to come out
Is your clinical AI tool safe? 4 questions to ask first
Alzheimer’s treatment works best early, so why are patients waiting?
Doctors can spot a failing patient. Can they spot a failing hospital?
Clinical trials answer drug questions. Health questions need other tools.
Shy doctors can lead: imposter syndrome and the path to physician leadership
Bringing a newborn home? What hospitals don’t tell new parents
